Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 2
2018 1
2019 1
2020 4
2021 6
2022 2
2023 6
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
[Hypoxic hepatitis].
Amadid H, Schiødt FV. Amadid H, et al. Ugeskr Laeger. 2014 Jan 20;176(4A):V08130501. Ugeskr Laeger. 2014. PMID: 25347249 Free article. Review. Danish.
[SGLT 2 inhibitors in Type 1 diabetes].
Stougaard EB, Amadid H, Søndergaard E, Jørgensen ME, Persson F, Rossing P. Stougaard EB, et al. Among authors: amadid h. Ugeskr Laeger. 2020 Aug 24;182(35):V05200351. Ugeskr Laeger. 2020. PMID: 32829747 Free article. Review. Danish.
Use of once-daily oral semaglutide and associated clinical outcomes among adults with type 2 diabetes in routine clinical practice in Canada: A multicentre, prospective real-world study (PIONEER REAL Canada).
Jain AB, Reichert SM, Amadid H, Braae UC, Bradley RM, Kim JW, Soo V, Yale JF. Jain AB, et al. Among authors: amadid h. Diabetes Obes Metab. 2024 May;26(5):1799-1807. doi: 10.1111/dom.15493. Epub 2024 Mar 11. Diabetes Obes Metab. 2024. PMID: 38468125
PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice.
Yabe D, Hamamoto Y, Kawanami D, Nishimura R, Terauchi Y, Amadid H, Braae UC, Major-Pedersen A, Suzuki R. Yabe D, et al. Among authors: amadid h. J Diabetes Investig. 2024 Nov;15(11):1566-1577. doi: 10.1111/jdi.14291. Epub 2024 Aug 22. J Diabetes Investig. 2024. PMID: 39172634 Free PMC article.
Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
Stougaard EB, Winther SA, Amadid H, Frimodt-Møller M, Persson F, Hansen TW, Rossing P. Stougaard EB, et al. Among authors: amadid h. PLoS One. 2021 Jul 30;16(7):e0254859. doi: 10.1371/journal.pone.0254859. eCollection 2021. PLoS One. 2021. PMID: 34329330 Free PMC article. Clinical Trial.
Physical Activity Dimensions Associated with Impaired Glucose Metabolism.
Amadid H, Johansen NB, Bjerregaard AL, Vistisen D, Færch K, Brage S, Lauritzen T, Witte DR, Sandbæk A, Jørgensen ME. Amadid H, et al. Med Sci Sports Exerc. 2017 Nov;49(11):2176-2184. doi: 10.1249/MSS.0000000000001362. Med Sci Sports Exerc. 2017. PMID: 28692629 Free PMC article.
Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study.
Bain SC, Carstensen B, Hyveled L, Seremetis S, Flindt Kreiner F, Amadid H, Clark A. Bain SC, et al. Among authors: amadid h. BMJ Open Diabetes Res Care. 2023 Jun;11(3):e003300. doi: 10.1136/bmjdrc-2022-003300. BMJ Open Diabetes Res Care. 2023. PMID: 37328273 Free PMC article. No abstract available.
27 results